Octagon Therapeutics

Developing better medicines for chronic autoimmune disease based on glycoimmune checkpoint biology. #checkpoint #immunology #autoimmune #inflammation

[Octagon Therapeutics @OctagonTx]

Octagon is hiring! See job posting below
https://t.co/6UOjMOSCoi

[Octagon Therapeutics @OctagonTx]

Learn about @OctagonTx approach to immune pathology and listen to CEO @isaacbstoner talkin about his journey in biotech!

https://t.co/CfAp3XbC2P

[Biorasi @Biorasi]

Tune in tomorrow for a new episode of @Biorasi's Few & Far Between podcast. Host Chris O'Brien welcomes Isaac Stoner, CEO at @OctagonTx, to the podcast to zoom in on #autoimmune disease, the role of the CEO, and effective funding strategies. #YourGoToCRO #clinicaltrials #CROs

[Octagon Therapeutics @OctagonTx]

We're excited to announce the addition of Liguo (Vicky) Wu to our core team! Dr. Wu brings a wealth of expertise in translational immunology and will play an important role in leading our R&D efforts.
#glycoimmunology #autoimmune #inflammation

[Octagon Therapeutics @OctagonTx]

Treatment approaches that deplete or suppress healthy immune cells put patients at risk.

@OctagonTx is developing immunomodulatory therapies that reset immune homeostasis while sparing protective immunity!

https://t.co/AjVQofShTN

[Isaac Stoner @isaacbstoner]

I'm very excited about Octagon's expanded Board of Directors. These veteran leaders are going to help power our novel immunomodulatory medicines into the clinic.

https://t.co/6ViSPup8dg

[Octagon Therapeutics @OctagonTx]

Listen to @OctagonTx co-founder @isaacbstoner discussing what it takes to build a biotech, current trends in the industry, and all sorts of other stuff!
https://t.co/Ugzj8LtaSu

[Isaac Stoner @isaacbstoner]

Octagon's updated website is live. Nice to be able to tell the world a little more about what we are doing.

And no, we did not sign on aging former pro-wrestlers to our Business Advisory Board!

@OctagonTx #autoimmunedisease #inflammation
https://t.co/OqBDTlD7Tg

[Octagon Therapeutics @OctagonTx]

We could not be more excited to announce this important milestone. Building a recognizable brand is often overlooked by fast-growing biotech companies. This is a big step forward for @OctagonTx

[Octagon Therapeutics @OctagonTx]

Are you looking for your next role at a fast-growing immunology company? Do you love science and care deeply about building better medicines for patients with #autoimmunedisease?

@OctagonTx is hiring:
- Lab Manager
- Research Scientist I
- other
[email protected]

[Octagon Therapeutics @OctagonTx]

We are excited to welcome new and existing investors into this equity financing round led by @SlaterTech_Fund.

Octagon is developing important immunomodulatory medicines for patients with chronic autoimmune and inflammatory diseases.

Onwards!

https://t.co/ovpcgT1qhe

[Octagon Therapeutics @OctagonTx]

Thinking hard about glycoimmunology at our weekly data review. Incredibly fun to be working with this many smart people on an important problem!

[Octagon Therapeutics @OctagonTx]

Wishing you a relaxing holiday season full of happiness and cheer and well-run lymphocyte analyses!

[Octagon Therapeutics @OctagonTx]

Glycans are fundamental to immunology and contain a tremendous amount of information!

https://t.co/q1MmByWqY0

[Isaac Stoner @isaacbstoner]

Glycoimmunology! Not just good for oncology...

@OctagonTx has made some fundamental discoveries around how this biology can drive autoimmune disease

[Octagon Therapeutics @OctagonTx]

We're thrilled to be adding Dr. Michael Elliott to the roster as we begin to move from discovery into development! His translational skills and experience are truly impressive.

[Octagon Therapeutics @OctagonTx]

Another really interesting example of the crucial role glycosylation has in immune development, activation, and response.

Glycoimmunology is eating the world

https://t.co/yrQbAeZ6DP

[Octagon Therapeutics @OctagonTx]

Glycosylation is fundamental to immune functioning (and pathology!), but the tools needed to study these humble carbohydrates are only now becoming available.

https://t.co/odTXobat3b

[Octagon Therapeutics @OctagonTx]

Glycoimmunology is starting to get some much-deserved attention! @OctagonTx has made some fundamental discoveries into how these humble sugar moieties drive #autoimmune disease and #inflammation

https://t.co/u22UZIJazq

[Octagon Therapeutics @OctagonTx]

Important resource!